FundedIQ
Biotechnology

Solstice Oncology: Funding, Investors & Team (Oct 2026)

Solstice Oncology is a clinical stage immuno-oncology company

www.solsticeoncology.com LinkedIn Boston, United States 11-50 employees Founded 2026
Total raised
$225M
Rounds
1
Latest
Series A
Sep 2026

Solstice Oncology has raised $225M across 1 funding round on record, the most recent a Series A of $225M announced in Sep 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Solstice Oncology Company Profile and Key Stats

Total funding raised
$225M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$225M in Sep 2026
Employees
11-50
reported band
Founded
2026
Headquarters
Boston, United States
Investors on record
3
3 named below

Latest funding round on record: Sep 2026.

Solstice Oncology Funding Rounds

Date
Round
Amount
Series A
$225M

Solstice Oncology Investors

RA Capital Management Forbion Capital Partners Canaan Partners

Solstice Oncology Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M
8,523
$15M

Solstice Oncology's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Solstice Oncology in Biotechnology and Boston

Companies Similar to Solstice Oncology

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Solstice Oncology Funding FAQs

What does Solstice Oncology do?

Solstice Oncology is a clinical stage immuno-oncology company

How much funding has Solstice Oncology raised?

Solstice Oncology has raised $225M across 1 round on record. The most recent is a Series A of $225M announced in Sep 2026.

When did Solstice Oncology last raise funding?

Solstice Oncology's most recent funding round on record is a Series A of $225M, announced in Sep 2026.

Who has invested in Solstice Oncology?

Investors on record for Solstice Oncology include RA Capital Management, Forbion Capital Partners, Canaan Partners.

Where is Solstice Oncology headquartered?

Solstice Oncology is based in Boston, United States.

How many employees does Solstice Oncology have?

Solstice Oncology is in the 11-50 employee band.

When was Solstice Oncology founded?

Solstice Oncology was founded in 2026.

How does Solstice Oncology's funding compare to other Biotechnology startups?

Solstice Oncology's latest round of $225M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Solstice Oncology Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solstice Oncology is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.